🇨🇦 12 months of P2Y12 receptor antagonist in Canada

12 months of P2Y12 receptor antagonist (12 months of P2Y12 receptor antagonist) regulatory status in Canada.

Marketing authorisation

12 months of P2Y12 receptor antagonist in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is 12 months of P2Y12 receptor antagonist approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for 12 months of P2Y12 receptor antagonist in Canada?

Beijing Anzhen Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.